A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
Dispatch Biotherapeutics
Varian, a Siemens Healthineers Company
Pfizer
Genmab
Anthos Therapeutics, Inc.
BigHat Biosciences, Inc.
Boehringer Ingelheim
Nammi Therapeutics Inc
Janssen Research & Development, LLC
Revolution Medicines, Inc.
Bayer
Turning Point Therapeutics, Inc.
GlaxoSmithKline
Cogent Biosciences, Inc.
Revolution Medicines, Inc.
AstraZeneca